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1. 
 
Abbreviations used in this paper
 
: DLG, discs large protein; MAGUK,
membrane-associated guanylate kinases.
 
T
 
he
 
 mechanisms that allow the nervous system of an-
imals to interpret and respond to their environment
requires an astonishing complexity of neuronal con-
nections and signaling pathways. The past decade has seen
the emergence of a common theme in the mechanisms me-
diating these seemingly complex tasks: during evolution,
nervous system development has taken components of less
complex cells and pathways and modified them to fit the re-
quirements of neuronal signaling. Neurexins were origi-
nally identified as a polymorphic family of neuronal-specific
type 1 cell surface membrane proteins that were postu-
lated to serve a unique role in specifying synaptic specific-
ity and docking synaptic vesicles at the active zone. How-
ever, recent genetic and molecular analyses have provided
novel insights that suggest neurexins are evolutionarily
conserved and mediate many aspects of cellular function.
 
Molecular Biology of Neurexins
 
Neurexins were first identified by Sdhof and colleagues
 
as cell surface receptors for 
 
a
 
-latrotoxin (19). This compo-
nent of black widow spider venom is well known for its po-
tent effects at the synapse, causing massive calcium-inde-
pendent release of neurotransmitters. Neurexins were also
found to interact with the synaptic vesicle calcium-binding
protein synaptotagmin (7, 19). These studies provided the
framework for an attractive model in which 
 
a
 
-latrotoxin
binds to neurexins, relaying a signal from the outside of
the synapse to the synaptic vesicle fusion machinery by ac-
tivating synaptotagmin. This model also suggested an in
vivo correlate that has been propagated throughout the
synaptic literature: neurexins may be involved in the for-
mation of the active zone by binding to postsynaptic re-
ceptors or extracellular matrix components and subse-
quently docking synaptic vesicles at these sites through an
interaction with synaptotagmin. A second clue to neu-
rexinÕs function was the report that they were selectively
enriched at synapses (24) and exhibited a striking number
of alternatively spliced forms (22). It was proposed that
the differential localization of various populations of alter-
natively spliced neurexins may allow them to function in
synaptic targeting (22).
Recent data have challenged these models of neurexin
function. These findings include the following observa-
tions: (
 
a
 
) Although Neurexin I
 
a
 
 binds 
 
a
 
-latrotoxin, their
interaction is calcium-dependent. 
 
a
 
-LatrotoxinÕs effects
are calcium independent, and a novel calcium-indepen-
dent ligand has now been identified as a candidate physio-
logical 
 
a
 
-latrotoxin receptor (4, 12). (
 
b
 
) 
 
a
 
-Latrotoxin still
causes exocytosis in mutant mice lacking Synaptotagmin I
(6), raising questions about whether a neurexinÐsynap-
totagmin interaction has a physiological role. (
 
c
 
) 
 
Drosoph-
ila
 
 and 
 
Discopyge
 
 homologues of neurexins have now
been identified, and they are expressed in cells other than
neurons and are not found at synapses (2, 19a). In addi-
tion, new studies have failed to repeat the reported pre-
synaptic localization of mammalian neurexins (23). Given
the challenges to the widely held views on neurexin func-
tion, we will review the recent literature and discuss the
possible role of these proteins in cell function.
To date, the neurexin family includes three related ver-
tebrate genes (NRX I, II, and III) (23, 24), a 
 
Drosophila
 
gene (NRX IV), and its human homologue (hNRX IV)
(2), which has recently been shown to be a contactin-asso-
ciated protein, Caspr (17, 18). A homologue of Neurexin
III
 
a
 
 has also been recently reported in the marine ray,
 
Discopyge ommata
 
, and a second 
 
Drosophila
 
 neurexin is
being characterized (Yuan, L., and B. Ganetzky, personal
communication). As shown in Fig. 1 
 
A
 
, the three verte-
brate neurexins encode an 
 
a
 
-isoform (1,507Ð1,578 amino
acids, 160Ð220 kD) and a 
 
b
 
-isoform (437Ð471 amino acids).
Neurexins have a large extracellular domain, a single trans-
membrane, and a short cytoplasmic segment (40Ð55 amino
acids). The extracellular portions of the 
 
a
 
-isoform contain
three EGF repeats, six repeats with low homology to the
G domain of laminin A, and an O-linked sugar domain
in proximity to the transmembrane segment. 
 
Drosophila
 
Neurexin IV contains two EGF repeats, five laminin G do-
 
mains, and an NH
 
2
 
-terminal Discoidin domain conserved
in hNRX IV/Caspr, but not present in Neurexins I, II, or
III. EGF and laminin G domains are present in a variety of
proteins that are components of the extracellular matrix or
involved in cell signaling, including laminin A, agrin, per-
lecan, and the 
 
Drosophila
 
 developmental proteins Crumbs
and Slit, and are thought to function in proteinÐprotein in-
teractions within the extracellular environment. The COOH-
terminal intracellular segment of neurexins contains a con-
served fourÐamino acid tail that functions as a recognition
sequence for the PDZ domains of membrane-associated
guanylate kinase (MAGUK)
 
1
 
 proteins (21). In addition,
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the intracellular domain also contains a putative protein
4.1 binding motif.
Given their amino acid sequence, neurexins are pre-
dicted to play a role in extracellular signaling or cell adhe-
sion. The splice variants of the vertebrate neurexins are
expressed in distinct populations of neurons, but their sub-
cellular localization is unknown. 
 
Drosophila
 
 Neurexin IV
is not expressed in neurons but instead localizes to septate
junctions of glia, epithelia, and ectodermally derived cells
(2). Septate junctions are thought to be the invertebrate
equivalent of tight junctions and represent sites of cell con-
tact and intercellular signaling. Septate and tight junctions
are also responsible for forming the bloodÐbrain barrier,
suggesting a role for glial-expressed neurexin in this pro-
cess. Human NRX IV/Caspr is widely expressed, including
in kidney, lung, and brain, and localizes to axons (2, 17).
hNRX IV/Caspr was identified by its interaction with the
axonally expressed Ig superfamily member contactin, which
interacts with glial receptor tyrosine phosphatase 
 
b
 
, again
suggesting a role in neuronalÐglial interactions (18). A
newly identified 
 
Discopyge
 
 neurexin is found in neurons
and perineural fibroblasts but does not localize to syn-
apses (19a). Instead, it localizes at sites of Schwann cellÐ
neuron contacts along the axon and at sites of perineural
fibroblast contact. A second neurexin homologue has been
identified in 
 
Drosophila
 
, and it is also expressed in glia
(Yuan, L., and B. Ganetzky, personal communication).
These localization studies indicate that the role of neurex-
ins is not confined to neurons and suggests that they may
participate in a variety of cellular interactions.
 
Neurexins: A Link Between the Extracellular 
Environment and Intracellular Signaling Pathways
 
Both molecular and genetic analysis suggests that neurex-
ins interact with several intracellular protein families of
known function. Yeast two-hybrid screening for interact-
ing partners with the rat neurexin intracellular domain
identified a ligand that was named CASK (8). The NH
 
2
 
-ter-
minal third of CASK has homology to the calmodulin-
binding and autoinhibitory domains of CAMKII. The
remaining COOH-terminal region of the protein shares
homology with the MAGUK family of proteins and con-
tains a PDZ domain, a Src homology 3 domain, and a
COOH-terminal catalytically inactive guanylate kinase
domain. CASK is expressed not only in neurons but in
many tissues, raising the possibility that additional neurex-
ins may interact with CASK outside the nervous system.
CASK interacts with all three vertebrate neurexins, and
this binding is abolished by deletion of the last three
amino acids of the intracellular COOH-terminal region of
neurexin (8). Several subclasses of sequence-specific inter-
actions involving the PDZ domains of MAGUK proteins
and the COOH-terminal amino acids of interacting pro-
teins have been defined and include the COOH-terminal
sequence EY
 
Y
 
/
 
F
I
 
/
 
V
 
, which is conserved in vertebrate and
 
Drosophila
 
 neurexins and is also present in the erythro-
cyte integral membrane protein glycophorin C (21). Ge-
netic studies also support an interaction with the MAGUK
family of proteins. In 
 
Drosophila
 
, the discs large protein
(DLG), another MAGUK member, is localized to both
synapses and septate junctions (13, 25), and genetic analy-
sis has shown that both DLG and neurexin function in the
assembly of septate junctions (2, 26). Interestingly, a new
protein with PDZ domains has been recovered in a yeast
two-hybrid screen using the 
 
Drosophila
 
 neurexin intracel-
lular domain as a bait (Bhat, M.A., unpublished data).
Thus, members of the PDZ-containing MAGUK family
represent a group of intracellular ligands for neurexins.
The MAGUK family is concentrated at cellular junc-
Figure 1. Domain structure of neurexins
and interacting proteins. (A) Neurexins
are type I integral membrane proteins
with a classical signal peptide and an ex-
tracellular domain with EGF and laminin
G repeats. The intracellular domain con-
tains a conserved recognition sequence for
PDZ domains and a motif homologous to
glycophorin C that has been shown to bind
protein 4.1. (B) Domain structure of the
MAGUK family and related proteins. (C)
The protein 4.1 family includes a con-
served 30-kD domain shown to bind gly-
cophorin C, calmodulin, and p55, and a
COOH-terminal 10-kD domain that medi-
ates interactions with the actin/spectrin cy-
toskeleton. (D) The neuroligin/gliotactin
family are type 1 transmembrane proteins
with a large extracellular domain homolo-
gous to the esterase family (e.g., acetylcholinesterase). (E) Sequence alignment of the protein 4.1 interacting domain of glycophorin C
with the neurexins. Yellow boxes represent identities with glycophorin C, while pink boxes indicate sequence similarities. Amino acids
conserved in all four proteins are indicated by asterisks. No sequence gaps have been introduced. This sequence motif is present intra-
cellularly in all four proteins shortly after the transmembrane-spanning segment ends and includes residues 65Ð80 of glycophorin C,
1239Ð1254 of Drosophila Neurexin IV, 1455Ð1470 of Neurexin I, and 1417Ð1432 of Neurexin III. SP, signal peptide; G1/G2, laminin G
domains; CHO, O-linked sugar domain; TM, membrane-spanning segment; 4.1m, protein 4.1 binding motif; MBD, MAGUK binding
domain; N, NH2 terminus; C, COOH terminus; 4.1, protein 4.1 binding site; GyK, guanylate kinase domain; CAMKII, calciumÐcalmod-
ulin kinase II homology domain; PTP1, protein tyrosine phosphatase domain; Bd 4.1, protein 4.1 30-kD homologous domain; Actin/
Spectrin, 10-kD cytoskeletal interacting domain; D., Drosophila. 
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tions and involved in clustering ion channels and organiz-
ing sites of intercellular communication (for review see
reference 20). Most MAGUK proteins contain one to three
PDZ domains, a Src homology 3 domain, a protein 4.1 rec-
ognition sequence, and a catalytically inactive guanylate
kinase domain. Members include the tight junctionÐassoci-
ated ZO-1 and ZO-2, the synaptic and septate junctionÐ
associated DLG, the postsynaptic PSD95/SAP90, the synap-
tic  and junctionalÐassociated human DLG homologue,
SAP97, the synaptic chapsyn 110/PSD93, the erythrocyte
membraneÐassociated p55, and the 
 
Caenorhabditis elegans
 
LIN-2A cellular junction signaling protein (Fig. 1 
 
B
 
).
DLG and PSD95 cluster Shaker-type K
 
1
 
 channels and
 
N
 
-methyl-
 
d
 
-aspartate receptors at synapses via their PDZ
domains (10, 11). PSD95 has been shown to bind and localize
neuronal nitric oxide synthase to synaptic membranes
through an interaction between PDZ domains (3). One miss-
ing link in this pathway is how the MAGUK proteins them-
selves are clustered at sites of contact given their intercel-
lular location. If neurexins were to localize to sites of cell
contact via interactions with extracellular or transmembrane
ligands, the intracellular domain could then recruit mem-
bers of the MAGUK family and assist in clustering and or-
ganizing ion channels and associated junctional proteins.
One question that arises from these studies is how a
neurexinÐMAGUK complex is linked to the underlying
cell cytoskeleton, a likely requirement for organizing sites
of cell contact. One candidate family of proteins perform-
ing such a task is the protein 4.1 family. In 
 
Drosophila
 
, the
protein 4.1 homologue, Coracle (5), along with DLG and
neurexin, are localized to septate junctions. In 
 
neurexin
 
mutants, protein 4.1 fails to localize to septate junctions, sug-
gesting that the intracellular COOH terminus of 
 
Drosophila
 
neurexin is required to localize protein 4.1 (2). This intra-
cellular domain is 68% similar to glycophorin C and con-
tains a conserved 12Ðamino acid protein 4.1 recognition
sequence ([16]; Fig. 1 
 
E
 
). The protein 4.1 recognition se-
quence, along with surrounding amino acids, is also con-
served in vertebrate neurexins and suggests a consensus
sequence of 
 
R
 
/
 
K
 
YXXRX
 
K
 
/
 
E
 
GXYXXE (Fig. 1 
 
E
 
). Another
mechanism that may recruit protein 4.1 to this complex is
the presence of a distinct protein 4.1 binding sequence
identified in p55, and which is conserved in many MAGUK
members ([16]; Fig. 1 
 
B
 
). The human DLG homologue has
also been shown to interact with protein 4.1 and its homo-
logue ezrin (14, 15), consistent with the MAGUK family
binding members of the protein 4.1 family. Thus, an inter-
action with CASK, which also contains a protein 4.1 bind-
ing motif, may provide an independent mechanism for ver-
tebrate neurexins to merge into this pathway and serve as
a membrane anchor to the underlying cytoskeleton. The
protein 4.1 family is widely expressed in many tissues, in-
cluding the brain, and includes ezrin, radixin, moesin, talin,
neurofibromatous 2/merlin, and protein 4.1 (Fig. 1 
 
C
 
).
These proteins are involved in modulating cytoskeletalÐ
membrane interactions, allowing regulation of cell adhe-
sion, shape, and mobility. The erythrocyte complex of gly-
cophorin C and protein 4.1 are required in vivo to localize
the MAGUK family member, p55, to the membrane and
to maintain cytoskeletalÐmembrane stability (16). The po-
tential for this pathway to organize sites of cell contact is
of general interest, but the finding that the MAGUK pro-
 
tein, DLG, and the protein 4.1 homologue, neurofibroma-
tous 2/merlin, are involved in tumor formation should
draw widespread attention. Thus, disrupting junctions re-
quired for cell communication and adhesion is a new path-
way for cellular overgrowth and tumor formation.
 
Extracellular Ligands for Neurexins
 
We have reviewed several intracellular protein families
suspected to be involved in neurexinÕs ability to link the
extracellular environment to the cytoskeleton (protein 4.1)
and intracellular clustering/signaling proteins (MAGUK).
An additional question is whether extracellular ligands in-
teract with neurexins at cellular junctions and maintain or
modify neurexin function. Using a recombinant splice-spe-
cific Neurexin I
 
b
 
 as a ligand, a type 1 transmembrane pro-
tein family (neuroligins) with homology to esterase pro-
teins (e.g., acetylcholinesterase and carboxylesterase) was
identified as a calcium-dependent extracellular ligand (9).
Neuroligins (836Ð848 amino acids, 95 kD) are expressed
within neurons and have a large extracellular esterase do-
main, a single transmembrane domain, and a cytoplasmic
tail of 
 
z
 
100 amino acids (Fig. 1 
 
D
 
). The extracellular do-
main lacks a serine residue at the active site, suggesting
that the protein is catalytically inactive, similar to the
 
Drosophila
 
 esterase proteins neurotactin and gliotactin.
Gliotactin (956 amino acids, 109 kD) is 50% similar to
neuroligin and is expressed in glial and epithelial cells, as is
 
Drosophila
 
 neurexin (1). Electrophysiological analysis of
 
gliotactin
 
 mutants have demonstrated a breakdown of the
bloodÐbrain barrier similar to that caused by mutations in
 
neurexin
 
 (1). Thus, in vitro studies in mammals suggest a
physical interaction between neurexins and the neuroligin/
gliotactin family, while in vivo genetic manipulations in
 
Drosophila
 
 indicate both proteins function in a similar
pathway. This interaction might form a transcellular scaf-
fold allowing neurexins to organize intracellular proteins
or may act in a ligand-receptor fashion, modifying neu-
rexinÕs interactions with the MAGUK and protein 4.1
families.
Recently, another extracellular ligand, contactin/ax-
onin-1, has been identified that binds hNRX IV/Caspr.
This axonally expressed member of the Ig superfamily has
been shown to bind glial receptor tyrosine phosphatase
 
b
 
, an interaction which is thought to play a role in axonal
growth (18).
 
Summary and Future Prospects
 
Recent in vitro and in vivo studies have provided exciting
insights suggesting that the neurexin family may function
in organizing cellular junctions. This model is supported
by the phenotypic analysis of 
 
Drosophila neurexin
 
 muta-
tions (2). These mutants lack the ladder-like transcellular
septate characteristic of septate junctions. In addition,
neurexin is required in glia to form the bloodÐbrain bar-
rier, consistent with an ability of neurexins to form trans-
cellular barriers at cellular junctions. Neurexin also localizes
protein 4.1 to sites of cell contact, and 
 
neurexin
 
 mutations
show defects in dorsal closure of the epidermis, a process
requiring extensive cellular movements and signaling. Fig.
2 presents a model of a cellular junction incorporating
neurexins. 
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Essential questions remain to be answered concerning
the neurexins. Foremost, a precise subcellular location of
the known vertebrate neurexins is required to determine if
they may also be involved in axonalÐglial interactions, sim-
ilar to that reported for the NRX IV homologue, hNRX
IV/Caspr. In addition, it will be important to extend the
search for nonneuronal neurexins, as a more complete
catalog of the neurexin family is required to begin to de-
termine the variety of roles these proteins might play in
cellular junctions. Do neurexins also play a role in the
MAGUKÕs ability to cluster ion channels at synapses, or is
their interaction with members of this protein family re-
stricted to other sites of cell contact? Do extracellular
ligands serve as activators or modulators of neurexinÕs link
to the intracellular environment, and how does the exten-
sive alternative splicing in vertebrate neurexins define or
modify these interactions? And finally, what, if any, cellu-
lar signals can be relayed through the neurexins? These
and other questions should inspire many interesting exper-
iments in the near future, as dissection of the role of neu-
rexins in cell junctions is just beginning.
 
Received for publication 21 February 1997.
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Figure 2. Model of neurexin interactions in cellular junctions.
(A) Hypothetical junction incorporating a neurexin-gliotactin/
neuroligin interaction with a link to the underlying cytoskeleton
via protein 4.1 and to intracellular signaling/clustering MAGUK
proteins. (B) A similar pathway connects the erythrocyte mem-
brane to the cytoskeleton via glycophorin C. (C) MAGUK mem-
bers have also been shown to cluster ion channels at synapses. It
is currently unclear if neurexins exist at synapses and are in-
volved in synapse formation, presynaptic vesicle docking, or
postsynaptic channel clustering. Current data favor a role for
neurexins in axonalÐglial interactions and cellular junctions in-
stead. Nrxphilin, Neurexophilin; SV, synaptic vesicle; DLG, discs
large protein/PSD95.